<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39431504</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1944-7884</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of acquired immune deficiency syndromes (1999)</Title><ISOAbbreviation>J Acquir Immune Defic Syndr</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review and Meta-analysis of the Impact of the COVID-19 Pandemic on Access to HIV Pre-exposure Prophylaxis: Lessons for Future Public Health Crises.</ArticleTitle><Pagination><StartPage>208</StartPage><EndPage>215</EndPage><MedlinePgn>208-215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/QAI.0000000000003488</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The World Health Organization is committed to strengthening access to pre-exposure prophylaxis (PrEP) for HIV prevention and its integration into primary care services. Unfortunately, the COVID-19 pandemic has disrupted the delivery of primary care, including HIV-related services. To determine the extent of this disruption, we conducted a systematic review and meta-analysis of the changes in access to PrEP services during the pandemic and the reasons for these changes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A search was conducted using PubMed, Scopus, Embase, PsycINFO, and Cinahl for studies published between January 2020 and January 2023. Selected articles described self-reported disruptions to PrEP service access associated with the COVID-19 pandemic or its responses. Pooled effect sizes were computed using a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirteen studies involving 12,652 PrEP users were included in our analysis. The proportion of participants reporting a disruption in access to PrEP services during the COVID-19 pandemic ranged from 3% to 56%, with a pooled proportion of 21% (95% confidence intervals: 8% to 38%). Social restrictions, financial constraints, and limited health insurance coverage were key factors affecting access to PrEP services during the pandemic.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To our knowledge, this is the first meta-analysis to quantify the extent of disruptions to accessing PrEP services because of the COVID-19 pandemic. To increase the ability of primary care services to maintain PrEP services during public health crises, a mixture of strategies is worth considering. These include multi-month PrEP prescriptions, telehealth services, deployment of peer support groups to provide a community-based service or home delivery, and provision of financial support interventions.</AbstractText><CopyrightInformation>Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wulandari</LastName><ForeName>Luh Putu Lila</ForeName><Initials>LPL</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negara</LastName><ForeName>Srila Nirmithya Salita</ForeName><Initials>SNS</Initials><AffiliationInfo><Affiliation>Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mashuri</LastName><ForeName>Yusuf Ari</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahyuningtias</LastName><ForeName>Siska Dian</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putra</LastName><ForeName>I Wayan Cahyadi Surya Distira</ForeName><Initials>IWCSD</Initials><AffiliationInfo><Affiliation>Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subronto</LastName><ForeName>Yanri W</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Riris Andono</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology, and Population Health, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thabrany</LastName><ForeName>Hasbullah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Public Health, Universitas Indonesia, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guy</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Law</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammoud</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bavinton</LastName><ForeName>Benjamin B</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaldor</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medland</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liverani</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Global Health and Development, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Probandari</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Tropical Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boettiger</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiseman</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>The Kirby Institute, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health and Development, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/V030825/1</GrantID><Agency>The United Kingdom National Institute for Health Research (UK NIHR) and UK Research Innovation (UKRI) through their Global Effort on COVID-19 (GECO) Health Research Funding Scheme.</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Acquir Immune Defic Syndr</MedlineTA><NlmUniqueID>100892005</NlmUniqueID><ISSNLinking>1525-4135</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065129" MajorTopicYN="Y">Pre-Exposure Prophylaxis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="Y">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding or conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39431504</ArticleId><ArticleId IdType="pmc">PMC11458105</ArticleId><ArticleId IdType="doi">10.1097/QAI.0000000000003488</ArticleId><ArticleId IdType="pii">00126334-202411010-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Estcourt C, Yeung A, Nandwani R, et al. . Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM. AIDS (London, England). 2021;35:665–673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924973</ArticleId><ArticleId IdType="pubmed">33290298</ArticleId></ArticleIdList></Reference><Reference><Citation>Grulich AE, Guy R, Amin J, et al. . Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5:e629–e637.</Citation><ArticleIdList><ArticleId IdType="pubmed">30343026</ArticleId></ArticleIdList></Reference><Reference><Citation>Phanuphak N, Sungsing T, Jantarapakde J, et al. . Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health. 2018;15:542–555.</Citation><ArticleIdList><ArticleId IdType="pubmed">30249317</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DK, Sullivan PS, Cadwell B, et al. . Evidence of an association of increases in pre-exposure prophylaxis coverage with decreases in human immunodeficiency Virus diagnosis rates in the United States, 2012-2016. Clin Infect Dis. 2020;71:3144–3151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819523</ArticleId><ArticleId IdType="pubmed">32097453</ArticleId></ArticleIdList></Reference><Reference><Citation>UNAIDS . Global AIDS Strategy 2021-2026—End Inequalities. End AIDS. Geneva: UNAIDS; 2021.</Citation></Reference><Reference><Citation>UNAIDS . Political Declaration on HIV and AIDS: Ending Inequalities and Getting on Track to End AIDS by 2030. Geneva: UNAIDS; 2021.</Citation></Reference><Reference><Citation>World Health Organization . Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. 2nd ed. Geneva: World Health Organization; 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27466667</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update. Geneva, Switzerland: World Health Organization; 2016.</Citation></Reference><Reference><Citation>United Nations General Assembly . Political Declaration on HIV and AIDS: On the Fast Track to Accelerating the Fight against HIV and to Ending the AIDS Epidemic by 2030. New York: United Nations; 2016.</Citation></Reference><Reference><Citation>WHO . Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022-2030. Geneva: World Health Organization; 2022.</Citation></Reference><Reference><Citation>World Health Organization . COVID-19 Public Health Emergency of International Concern (PHEIC) Global Research and Innovation Forum. Geneva: World Health Organization; 2020.</Citation></Reference><Reference><Citation>World Health Organization . WHO COVID-19 Dashboard. Geneva: World Health Organization; 2024.</Citation></Reference><Reference><Citation>Global HIV Prevention Coalition . Preventing HIV Infections at the Time of a New Pandemic: A Synthesis Report on Programme Disruptions and Adaptations during the COVID-19 Pandemic in 2020. Geneva: UNAIDS; 2020.</Citation></Reference><Reference><Citation>Kiarie H, Temmerman M, Nyamai M, et al. . The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysis. Lancet Glob Health. 2022;10:e1257–e1267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363041</ArticleId><ArticleId IdType="pubmed">35961349</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S, Mirzapour P, Pashaei Z, et al. . The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review. AIDS Res Ther. 2023;20:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9821373</ArticleId><ArticleId IdType="pubmed">36609313</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer D, Slone SE, Ogungbe O, et al. . Impact of the COVID-19 pandemic on HIV healthcare service engagement, treatment adherence, and viral suppression in the United States: a systematic literature review. AIDS Behav. 2023;27:344–357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9344234</ArticleId><ArticleId IdType="pubmed">35916951</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao A, Rucinski K, Jarrett BA, et al. . Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries. J Acquir Immune Defic Syndr. 2021;87:644–651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276834</ArticleId><ArticleId IdType="pubmed">33443963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong C, Horvath KJ, Stephenson R, et al. . PrEP use and persistence among young sexual minority men 17-24 Years old during the COVID-19 pandemic. AIDS Behav. 2022;26:631–638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8361406</ArticleId><ArticleId IdType="pubmed">34387777</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey DLJ, Bekker L-G, Mashele N, et al. . PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa. Lancet HIV. 2020;7:e735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7398649</ArticleId><ArticleId IdType="pubmed">32758479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YT, Duncan DT, Del Vecchio N, et al. . COVID-19-Related stressors, sex behaviors, and HIV status neutral care among black men who have sex with men and transgender women in Chicago, USA. J Acquir Immune Defic Syndr. 2021;88:261–271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8518204</ArticleId><ArticleId IdType="pubmed">34310447</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCarthy S, Izenberg M, Barreras JL, et al. . Rapid mixed-methods assessment of COVID-19 impact on Latinx sexual minority men and Latinx transgender women. PLoS One. 2020;15:e0244421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7774921</ArticleId><ArticleId IdType="pubmed">33382752</ArticleId></ArticleIdList></Reference><Reference><Citation>Legesse AY, Hadush Z, Teka H, et al. . Lived experience of healthcare providers amidst war and siege: a phenomenological study of Ayder Comprehensive Specialized Hospital of Tigray, Northern Ethiopia. BMC Health Serv Res. 2024;24:292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10916075</ArticleId><ArticleId IdType="pubmed">38448988</ArticleId></ArticleIdList></Reference><Reference><Citation>Elnakib S, Elaraby S, Othman F, et al. . Providing care under extreme adversity: the impact of the Yemen conflict on the personal and professional lives of health workers. Soc Sci Med. 2021;272:113751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7938221</ArticleId><ArticleId IdType="pubmed">33588206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesesew H, Berhane K, Siraj ES, et al. . The impact of war on the health system of the Tigray region in Ethiopia: an assessment. BMJ Glob Health. 2021;6:e007328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611430</ArticleId><ArticleId IdType="pubmed">34815244</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman JA, Weitzman A. Effects of the 2010 Haiti earthquake on women's reproductive health. Stud Fam Plann. 2016;47:3–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">27027990</ArticleId></ArticleIdList></Reference><Reference><Citation>Djafri D, Chongsuvivatwong V, Geater A. Effect of the September 2009 Sumatra earthquake on reproductive health services and MDG 5 in the city of Padang, Indonesia. Asia Pac J Public Health. 2015;27:Np1444–1456.</Citation><ArticleIdList><ArticleId IdType="pubmed">24097920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray-Bennett NS, Corsel DMJ, Goswami N, et al. . Understanding reproductive health challenges during a flood: insights from Belkuchi Upazila, Bangladesh. Gates Open Res. 2019;3:788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6603260</ArticleId><ArticleId IdType="pubmed">31294418</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay G, Black B, Mbambu Kahamba S, et al. . Not All that Bleeds Is Ebola: How Has the DRC Ebola Outbreak Impacted Sexual and Reproductive Health in North-Kivu? New York, NY: The International Rescue Committee; 2019.</Citation></Reference><Reference><Citation>WHO. Building Health Systems Resilience for Universal Health Coverage and Health Security during the COVID-19 Pandemic and beyond: A Brief on the WHO Position; 2021.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7:177–188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JP, et al. . A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97–111.</Citation><ArticleIdList><ArticleId IdType="pubmed">26061376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan R, CCaCRG. Heterogeneity and Subgroup Analyses in Cochrane Consumers and Communication Group Reviews: Planning the Analysis at Protocol Stage. UK: Cochrane Consumers and Communication Review Group; 2016.</Citation></Reference><Reference><Citation>Ford N, Patten G, Rangaraj A, et al. . Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis. Lancet HIV. 2022;9:e150–e159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905089</ArticleId><ArticleId IdType="pubmed">35245507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottawa Hospital Research Institute, University of Oxford, Monash University. PRISMA: transparent reporting of systematic reviews and meta-analyses; 2009. Available at: http://www.prisma-statement.org/. Accessed June 16, 2016.</Citation></Reference><Reference><Citation>The Joanna Briggs Institute . The Joanna Briggs Institute Critical Appraisal Tools for Use in JBI Systematic Reviews: Checklist for Prevalence Studies. Adelaide: The Joanna Briggs Institute; 2017.</Citation></Reference><Reference><Citation>Tola A, Assefa N, Dessie Y, et al. . Epidemiology of hyperglycemia during pregnancy in Ethiopia: prevalence, associated factors, and feto-maternal outcomes: systematic review and meta-analysis. Syst Rev. 2024;13:116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11057183</ArticleId><ArticleId IdType="pubmed">38685068</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres TS, Hoagland B, Bezerra DRB, et al. . Impact of COVID-19 pandemic on sexual minority populations in Brazil: an analysis of social/racial disparities in maintaining social distancing and a description of sexual behavior. AIDS Behav. 2021;25:73–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7394046</ArticleId><ArticleId IdType="pubmed">32737817</ArticleId></ArticleIdList></Reference><Reference><Citation>World Bank . World Bank Country and Lending Groups. Washington, DC: World Bank; 2024.</Citation></Reference><Reference><Citation>Camp C, Saberi P. Facilitators and barriers of 2-1-1 HIV preexposure prophylaxis. PLoS ONE. 2021;16:e0251917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136636</ArticleId><ArticleId IdType="pubmed">34014998</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaccio MD, Villes V, Michels D, et al. . Impact of the early 2020 COVID-19 crisis and lockdown on PrEP use among men who have sex with men (MSM) in France. Sex Transm Infections. 2022;98:510–517.</Citation><ArticleIdList><ArticleId IdType="pubmed">35149580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammoud MA, Grulich A, Holt M, et al. . Substantial decline in use of HIV preexposure prophylaxis following introduction of COVID-19 physical distancing restrictions in Australia: results from a prospective observational study of gay and bisexual men. J Acquir Immune Defic Syndr. 2021;86:22–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727320</ArticleId><ArticleId IdType="pubmed">33027151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistler CB, Curley CM, Rosen AO, et al. . The impact of COVID-19 on access to HIV prevention services among opioid-dependent individuals. J Community Health. 2021;46:960–966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996112</ArticleId><ArticleId IdType="pubmed">33770334</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan E, Caba AE, Eaton LA, et al. . PrEP access affected by COVID-19 is associated with increased odds of HIV seroconversion. J Acquir Immune Defic Syndr. 2022;91:138–143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10284373</ArticleId><ArticleId IdType="pubmed">36094479</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampati S, Emrick K, Siegler AJ, et al. . Changes in sexual behavior, PrEP adherence, and access to sexual health services because of the COVID-19 pandemic among a cohort of PrEP-using MSM in the south. J Acquir Immune Defic Syndr. 2021;87:639–643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8533029</ArticleId><ArticleId IdType="pubmed">33512848</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyniers T, Rotsaert A, Thunissen E, et al. . Reduced sexual contacts with non-steady partners and less PrEP use among MSM in Belgium during the first weeks of the COVID-19 lockdown: results of an online survey. Sex Transm Infections. 2021;97:414–419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7656903</ArticleId><ArticleId IdType="pubmed">33172917</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson R, Chavanduka TMD, Rosso MT, et al. . Sex in the time of COVID-19: results of an online survey of gay, bisexual and other men who have sex with men's experience of sex and HIV prevention during the US COVID-19 epidemic. AIDS Behav. 2021;25:40–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7464052</ArticleId><ArticleId IdType="pubmed">32876905</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford FW, Wu J, Heimer R. Hidden population size estimation from respondent-driven sampling: a network approach. J Am Stat Assoc. 2018;113:755–766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6392194</ArticleId><ArticleId IdType="pubmed">30828120</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YLA, Zhu W, Wiener J, et al. . Impact of coronavirus disease 2019 (COVID-19) on human immunodeficiency Virus (HIV) pre-exposure prophylaxis prescriptions in the United States-A time-series analysis. Clin Infect Dis. 2022;75:e1020–e1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8807241</ArticleId><ArticleId IdType="pubmed">35040928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong C, Huh D, Schnall R, et al. . Changes in high-risk sexual behavior, HIV and other STI testing, and PrEP use during the COVID-19 pandemic in a longitudinal cohort of adolescent men who have sex with men 13 to 18 years old in the United States. AIDS Behav. 2023;27:1133–1139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9511439</ArticleId><ArticleId IdType="pubmed">36156174</ArticleId></ArticleIdList></Reference><Reference><Citation>Iain H, Diarmuid N, Gary George W, et al. . COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK. Sex Transm Infections. 2021;97:521–524.</Citation><ArticleIdList><ArticleId IdType="pubmed">33462118</ArticleId></ArticleIdList></Reference><Reference><Citation>Howarth AR, Saunders J, Reid D, et al. . “Stay at home …”: exploring the impact of the COVID-19 public health response on sexual behaviour and health service use among men who have sex with men: findings from a large online survey in the UK. Sex Transm Infect. 2022;98:346–352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457994</ArticleId><ArticleId IdType="pubmed">34544888</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikanth K, Killelea A, Strumpf A, et al. . Associated costs are a barrier to HIV preexposure prophylaxis access in the United States. Am J Public Health. 2022;112:834–838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9137017</ArticleId><ArticleId IdType="pubmed">35420893</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger ZD, Golub SA, Borges C, et al. . Reasons for PrEP discontinuation after navigation at sexual health clinics: interactions among systemic barriers, behavioral relevance, and medication concerns. J Acquir Immune Defic Syndr. 2022;90:316–324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9203912</ArticleId><ArticleId IdType="pubmed">35286280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan C, Fraser D, Vaccher S, et al. . Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: results from the MI-EPIC clinical trial. Sex Health. 2022;18:453–459.</Citation><ArticleIdList><ArticleId IdType="pubmed">34895427</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar M, Grey C, Wells A, et al. . Public health morality, sex, and COVID-19: sexual minority men's HIV pre-exposure prophylaxis (PrEP) decision-making during Ontario's first COVID-19 lockdown. Crit Public Health. 2022;32:116–126.</Citation></Reference><Reference><Citation>Qiao S, Li Z, Weissman S, et al. . Disparity in HIV service interruption in the outbreak of COVID-19 in South Carolina. AIDS Behav. 2021;25:49–57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453068</ArticleId><ArticleId IdType="pubmed">32856176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedado D, Kaso AW, Hailu A. Magnitude and determinants of out of pocket health expenditure among patients visiting outpatients in public hospitals in East Shoa Zone, Ethiopia. Clin Epidemiol Glob Health. 2022;15:101066.</Citation></Reference><Reference><Citation>Wirawan GB, Wardhani BDK, Pradnyani PE, et al. . Behavioral changes, adaptation, and supports among Indonesian female sex workers facing dual risk of COVID-19 and HIV in a pandemic. Int J Environ Res Public Health. 2022;19:1361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8835319</ArticleId><ArticleId IdType="pubmed">35162384</ArticleId></ArticleIdList></Reference><Reference><Citation>Iversen J, Sabin K, Chang J, et al. . COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses. J Int AIDS Soc. 2020;23:e25632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594630</ArticleId><ArticleId IdType="pubmed">33119183</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke GR, Sosnowy C, Zanowick-Marr A, et al. . Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States. BMC Infect Dis. 2022;22:1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9354303</ArticleId><ArticleId IdType="pubmed">35931953</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention: US Public Health Service . Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update: A Clinical Practice Guideline. Atlanta: Centers for Disease Control and Prevention; 2018.</Citation></Reference><Reference><Citation>Xiridou M, Heijne J, Adam P, et al. . How the disruption in sexually transmitted infection care due to the COVID-19 pandemic could lead to increased sexually transmitted infection transmission among men who have sex with men in The Netherlands: a mathematical modeling study. Sex Transm Dis. 2022;49:145–153.</Citation><ArticleIdList><ArticleId IdType="pubmed">34475357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoagland B, Torres TS, Bezerra DRB, et al. . Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Braz J Infect Dis. 2020;24:360–364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261432</ArticleId><ArticleId IdType="pubmed">32504552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerzner M, De AK, Yee R, et al. . Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries. PLoS One. 2022;17:e0266280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8982838</ArticleId><ArticleId IdType="pubmed">35381024</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirke S, Quinn L, Hegarty D, et al. . Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19. Int J STD AIDS. 2021;32:100–103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7817984</ArticleId><ArticleId IdType="pubmed">33050787</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips TR, Fairley CK, Donovan B, et al. . Sexual health service adaptations to the coronavirus disease 2019 (COVID-19) pandemic in Australia: a nationwide online survey. Aust N Z J Public Health. 2021;45:622–627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652521</ArticleId><ArticleId IdType="pubmed">34473388</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson L, Gibbs J, Quinn J, et al. . Maintaining access to HIV pre-exposure prophylaxis in a pandemic: a service evaluation of telephone-based pre-exposure prophylaxis provision. Int J STD AIDS. 2022;33:718–721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189322</ArticleId><ArticleId IdType="pubmed">35465791</ArticleId></ArticleIdList></Reference><Reference><Citation>Matambanadzo P, Busza J, Mafaune H, et al. . It went through the roof": an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19. J Int AIDS Soc. 2021;24:e25813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554216</ArticleId><ArticleId IdType="pubmed">34713613</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh F Von Lingen A Cigan B, et al. . How Has the COVID-19 Response Changed Medicine Deliveries for People Living with or at Risk of HIV? Glasgow, Scotland: HIV Glasgow Congress; 2020.</Citation></Reference><Reference><Citation>Rosen JG, Zhang L, Pelaez D, et al. . Provider perspectives on HIV pre-exposure prophylaxis service disruptions and adaptations during the COVID-19 pandemic in Baltimore, Maryland: a qualitative study. AIDS Patient Care STDS. 2022;36:313–320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9419971</ArticleId><ArticleId IdType="pubmed">35951445</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulandari LPL, Negara SNS, Wahyuningtias SD, et al. . Delivering HIV and TB services amidst the COVID-19 pandemic in Indonesia: a qualitative study of challenges and mitigation strategies. J Glob Health Rep. 2024;8.</Citation></Reference><Reference><Citation>Mashuri YA, Boettiger D, Wahyuningtias SD, et al. . “I pity the TB patient”: a mixed methods study assessing the impact of the COVID-19 pandemic on TB services in two major Indonesian cities and distilling lessons for the future. BMJ Glob Health. 2024;9:e014943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11103193</ArticleId><ArticleId IdType="pubmed">38760026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoagland B, Torres TS, Bezerra DRB, et al. . High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Braz J Infect Dis. 2021;25:101037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833416</ArticleId><ArticleId IdType="pubmed">33285137</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth AM, Tran NK, Felsher M, et al. . Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the project SHE demonstration study. J Acquir Immune Defic Syndr. 2021;86:e61–e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7878321</ArticleId><ArticleId IdType="pubmed">33148998</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa NW, Weimer M, Willenburg KS, et al. . Expansion of preexposure prophylaxis capacity in response to an HIV outbreak among people who inject drugs-cabell county, West Virginia, 2019. Public Health Rep. 2022;137:25–31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721767</ArticleId><ArticleId IdType="pubmed">33646890</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd AT, Jahun I, Dirlikov E, et al. . Expanding access to HIV services during the COVID-19 pandemic-Nigeria, 2020. AIDS Res Ther. 2021;18:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449993</ArticleId><ArticleId IdType="pubmed">34538268</ArticleId></ArticleIdList></Reference><Reference><Citation>Latkin CA, Mai NVT, Ha TV, et al. . Social desirability response bias and other factors that may influence self-reports of substance use and HIV risk behaviors: a qualitative study of drug users in Vietnam. AIDS Educ Prev. 2016;28:417–425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5268760</ArticleId><ArticleId IdType="pubmed">27710083</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>